FLAURA2: Osi ± CT in EGFR+ NSCLC
FLAURA2: Phase III Trial of First-line Osimertinib ± Platinum-Based Chemotherapy in EGFR-Mutated Advanced NSCLC

Released: September 14, 2023

Activity

Progress
1
Course Completed